CAS: 72741-87-8; Swainsonine

该化合物是一种自然产生的具有大量生物化学和药理应用的多利zidine alkaroid,它作为α-mannosidase和Golgi mannosidase II的强大和选择性抑制剂,干扰N-联结的甘蛋白处理.这个机制使它成为研究甘基蛋白生物合成和淋巴菌储存紊乱的宝贵工具.Swainsonine还展示了临床前研究中的免疫细胞和抗肿瘤特性,特别是在改变肿瘤细胞粘合和转移方面.它的高度纯度和精细化的活动确保了在基因生物学,肿瘤学和免疫学研究中的实验用途的可靠性.该化合物通常作为淋病粉供应,确保实验室应用的稳定性和重新构造的便利性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号162470-36-2 (-)-8-benzyloxy... | CAS号85624-09-5 1,2-ISOPROPYLID... | CAS号1002754-00-8 3-((2R,3S,4S,5S... | CAS号72741-89-0 Acetic acid (1S... | CAS号130412-86-1 (1S,2R,8R,8aR)-... | CAS号129421-04-1 (1S,2R,8R,8aR)-... | CAS号253778-10-8 [1S,2R,8R,8aR]-... | CAS号1148122-99-9 (3aR,9R,9aS,9bS... | CAS号154815-12-0 (3aR,9R,9aR,9bS...

合成工艺路线路线简述

    在 盐酸,Lithium Aluminium Tetrahydride体系中,用 甲醇,四氢呋喃 作为反应溶剂,化学反应 11.0H,以90%的收率获得产物八倾吲嗪三醇
    参考文献:一种制备苦马豆素[(-)-Swainsonine]的方法
    标题:一种制备苦马豆素[(-)-Swainsonine]的方法
    摘要:本发明属于化学合成领域,涉及具有抗癌活性苦马豆素[(‑)‑swainsonine]的制备方法.本发明所述制备苦马豆素[(‑)‑swainsonine]的技术路线,操作简单,路线简洁,收率较高,所用的试剂均为常用试剂.本发明方法制备苦马豆素[(‑)‑swainsonine]的成本能明显降低,在实验室中可方便实现10‑100克级的制备,可适合大规模制备.

    海关参考信息

    专利信息


    专利号:US-5187279-A
    优先权日:1990-07-27
    标题:Synthesis of (-) swainsonine and intermediate compounds employed in such synthesis
    发明人:CHA JIN K; BENNETT III RICHARD B
    权利人:CHA JIN K; BENNETT III RICHARD B
    摘要:(-)-Swainsonine is prepared by the steps of first reacting a compound having the formula: ##STR1## wherein each R 2 is lower alkyl, with (4-carbalkoxybutyl) triphenylphosphonium bromide in a strong base to obtain an alcohol having the formula: ##STR2## wherein R 2 is as defined above and R is C 1 -C 8 alkyl; the alcohol is then reacted with methanesulfonyl chloride or p-toluenesulfonyl chloride or benzenesulfonyl chloride in the presence of a tertiary amine to obtain the corresponding sulfonate. Heating the sulfonate with an azide in an organic solvent yields an imine having the formula: ##STR3## wherein R 2 and R are ad defined above. Treating the imine with an inorganic base, in aqueous alcohol provides upon acidification, the corresponding acid. Heating the acid at reflux temperature in organic solvent, yields an enamide having the formula: ##STR4## wherein R 2 is as defined above. Treating the enamide with diborane followed by reaction with hydrogen peroxide provides a protected swainsonine having the formula: ##STR5## which upon acid hydrolysis gives swainsonine.

    专利号:WO-9006311-A1
    优先权日:1988-11-29
    标 题 :Synthesis of (-)-swainsonine and intermediate compounds employed in such synthesis
    发明人:CHA JIN KUN; BENNETT RICHARD BERNARD III
    权利人:UNIV VANDERBILT
    摘要:A method of synthesizing swainsonine and its analogues employing a unique intermediate imine and a unique intermediate enamide.

    专利号:US-5484925-A
    优先权日:1990-07-27
    标题:Synthesis of (-)-swainsonine and intermediate compounds employed in such synthesis
    发明人:CHA JIN K; BENNETT III RICHARD B
    摘要:Enamides of the formula: ##STR1## wherein each R 2 when taken independently represents alkoxymethyl or arylmethyl and when taken together represent alkylene bridging the oxygen atoms to which they are bonded; and R 3 represents oxygen or hydrogen; are described as useful intermediates in a process for preparing swainsonine.

    专利号:WO-2023008461-A1
    优先权日:2021-07-27
    标题:Medicament for treatment and/or prevention of cancer
    发明人:KUME MASAHIKO; OKANO FUMIYOSHI; SAITO TAKANORI
    权利人:TORAY INDUSTRIES
    摘要:The present invention relates to a medicament for the treatment and/or prevention of cancer, the medicament being characterized by comprising an antibody having an immunological reactivity with CAPRIN-1 protein or a fragment of the antibody and a drug capable of inhibiting the N-glycoside-linked sugar chain synthesis of a glycoprotein which are combined with each other in a blended or separated form.

    专利号:US-2007293456-A9
    优先权日:2004-12-30
    标题:Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
    发明人:HAYFORD ANTHONY; KALOKO JOSEPH
    权利人:HAYFORD ANTHONY; KALOKO JOSEPH
    摘要:A method of making a compound of Formula I: n n ncomprises reacting a compound of Formula II n n nwith a compound such as R 1 OH or R 1 SH, to produce said compound of Formula I. Compounds of Formula I are useful, among other things, as dyes, spectral sensitizers, glycosidase inhibitors, and as antibacterial, antiviral, and anti-inflammatory agents.

    专利号:US-6051711-A
    优先权日:1997-10-24
    标 题 :Synthesis of swainsonine salts
    发明人:TROPPER FRANCOIS; SHAH RAJAN N; SHARMA PRADEEP
    权利人:GLYCODESIGN INC
    摘要:A method for synthesizing swainsonine salts and intermediates thereof comprising subjecting a compound of the formula I wherein R2 and R2' are the same or different and represent alkyl, halogen, alkenyl, alkoxy, cycloalkyl or aryl which may be substituted, to acid hydrolysis in the presence of a C1-4 alkanol to obtain a crystalline salt of swainsonine; and optionally, recrystallizing the swainsonine salt from a C1-4 alkanol. The reaction may be used in combination with one or more additional reaction steps.
    上海祥耕科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sharingtechcn.com
    电话: 0086 (21) 6049-5188👤
    📞上海祥耕科技发展有限公司 ⚠️参考联系方式

    销售电话:0086 (21) 6049-5188
    邮箱:sharing@sharingtechcn.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Cook D, Gardner DR, Pfister JA, Lee ST, Welch KD, Welsh SL. A Screen for Swainsonine in Select North American Astragalus Species. Chem Biodivers. 2017 Apr;14(4). doi: 10.1002/cbdv.201600364. Epub 2017 Mar 23. doi: 10.1016/j.toxicon.2016.09.012. Epub 2016 Sep 16. doi: 10.1016/j.etap.2016.08.018. Epub 2016 Aug 31. Review. doi: 10.4014/jmb.1709.09003. Review. doi: 10.1021/jf501674r. Epub 2014 May 6. Review. doi: 10.1016/j.toxicon.2017.09.014. Epub 2017 Sep 28. doi: 10.1021/ol202747p. Epub 2011 Nov 14. doi: 10.1021/np400274n. Epub 2013 Sep 20. doi: 10.1155/2016/6824374. Epub 2016 Nov 24.
    11: Si CM, Mao ZY, Dong HQ, Du ZT, Wei BG, Lin GQ. Divergent Method to trans-5-Hydroxy-6-alkynyl/alkenyl-2-piperidinones: Syntheses of (-)-Epiquinamide and (+)-Swainsonine. J Org Chem. 2015 Jun 5;80(11):5824-33. doi: 10.1021/acs.joc.5b00803. Epub 2015 May 20. doi: 10.1016/j.toxicon.2015.01.002. Epub 2015 Jan 5. doi: 10.1039/c6ob00531d. doi: 10.1021/acs.orglett.6b00030. Epub 2016 Feb 16. doi: 10.1186/s12917-015-0336-6.
    16: Dhand V, Draper JA, Moore J, Britton R. A short, organocatalytic formal synthesis of (-)-swainsonine and related alkaloids. Org Lett. 2013 Apr 19;15(8):1914-7. doi: 10.1021/ol400566j. Epub 2013 Apr 3. doi: 10.1021/jf103551t. Epub 2011 Jan 7. doi: 10.1007/s10886-017-0820-5. Epub 2017 Feb 11. doi: 10.1021/jf4008423. Epub 2013 Apr 12. doi: 10.1371/journal.ppat.1003158. Epub 2013 Feb 7.

    合成参考文献


    参考文献:10.1016/j.phymed.2011.06.005
    摘要:Santos FM, Latorre AO, Hueza IM, Sanches DS, Lippi LL, Gardner DR, Spinosa HS. Increased antitumor efficacy by the combined administration of swainsonine and cisplatin in vivo. Phytomedicine. 2011 Sep 15;18(12):1096–101. doi: 10.1016/j.phymed.2011.06.005.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知